Skip to content

Clinical trials

Completed Schizophrenia trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Bulgaria Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20051
20073
20086
20093
20104
20113
20122
20135
20142
20152
20165
20172
20182
20193
20202
20214
20224
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alkermes, Inc.8
Otsuka Pharmaceutical Development & Commercialization, Inc.8
AstraZeneca6
Janssen Research & Development, LLC6
Janssen-Cilag International NV4
ACADIA Pharmaceuticals Inc.3
AbbVie2
H. Lundbeck A/S2
Hoffmann-La Roche2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia58
Psychotic Disorders5
Bipolar Disorder2
Mental Disorders2
Recurrence2
Schizophrenia Spectrum and Other Psychotic Disorders2
Alcoholism1
Autistic Disorder1
Cognitive Dysfunction1
Depressive Disorder1

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.